Name: Adaptive Biotechnologies Corporation (ADPT) Financial Statements
Creator: FinSpry

Adaptive Biotechnologies Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Adaptive Biotechnologies Corporation income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Revenue & Gross Profit
Revenue	276.98	178.96	170.28	185.31	154.34	98.38	85.07
Cost of Revenue	165.13	175.03	75.55	57.91	49.30	138.60	22.27
Gross Profit	111.85	3.92	94.72	127.40	105.04	-40.22	62.80
Operating Expenses
Research & Development	0.00	85.87	122.12	141.76	142.34	116.07	70.71
Selling, General & Administrative	167.27	157.57	172.51	184.13	169.97	110.89	68.79
Operating Expenses	168.97	159.27	296.33	327.59	314.01	112.60	141.19
Operating Income	-57.12	-155.34	-201.61	-200.19	-208.97	-152.82	-78.39
Other Income/Expense
Interest Income	9.44	6.33	15.53	4.06	1.67	7.36	0.00
Interest Expense	-11.78	-11.58	13.80	4.24	0.00	0.00	0.00
Other Income/Expense	0.00	2.95	-25.43	99.36	95.79	69.82	2.27
Income
Income Before Tax	-59.46	-159.60	-225.30	-200.37	-207.30	-146.23	-68.61
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	2.10
Net Income	-59.50	-159.49	-225.25	-200.19	-207.28	-146.23	-68.61
Net Income - Continuous Operations	0.00	-159.49	-225.30	-200.37	-207.30	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-38.94	-136.09	-189.27	-175.21	-193.35	-144.35	-65.27
EBIT	-57.12	-155.34	-211.50	-196.13	-207.30	-152.82	-68.61
Depreciation & Amortization	18.18	19.26	1.70	1.70	1.70	8.47	1.70
Earnings Per Share
Basic EPS	-	-1.00	-2.00	-1.00	-1.00	-1.00	-1.00
Diluted EPS	-	-1.00	-2.00	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	151.72	147.10	144.38	142.52	140.35	131.22	69.17
Diluted Shares Outstanding	151.72	147.10	144.38	142.52	140.35	131.22	69.17